ELEN TYLKIN: Open Payments
NPI 1043306111 · LIBERTYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 31 payments from 9 companies in 2025. Trend: 2023 $548 · 2024 $728 · 2025 $671
Food & beverage: $632Education: $39
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $231 |
| Alkermes, Inc. | 7 | $157 |
| Lundbeck LLC | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: REXULTI, LYBALVI, ARISTADA, TRINTELLIX, UBRELVY, Auvelity, CAPLYTA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
